Search research articles
Contact Us
Filters
Showing results (61-70 of 269) with videos related to
Page
of 27
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 22, 2020
Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis
Gabriela R Oates, Elizabeth Baker, Steven M Rowe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 20, 2024
Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL)
Elizabeth Baker, William T Harris, Jennifer S Guimbellot, et al.
Genes
|
June 4, 2020
Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis
Zhongyu Liu, Justin D Anderson, Lily Deng, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 3, 2007
Bioelectric effects of quinine on polarized airway epithelial cells
Eleanor Bates, Stacey Miller, Mariah Alexander, et al.
ERJ Open Research
|
October 1, 2025
<i>Aspergillus fumigatus</i> is influenced by mucus accumulation, airway inflammation and cystic fibrosis transmembrane conductance regulator function
T Spencer Poore, Anh Nguyen, Levi Schaefers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2014
Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor
Sonya L Heltshe, Nicole Mayer-Hamblett, Jane L Burns, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
September 3, 2020
G551D mutation impairs PKA-dependent activation of CFTR channel that can be restored by novel GOF mutations
Wei Wang, Lianwu Fu, Zhiyong Liu, et al.
Pediatric Pulmonology
|
April 14, 2020
Ataluren/ivacaftor combination therapy: Two N-of-1 trials in cystic fibrosis patients with nonsense mutations
Jacelyn E Peabody Lever, Venkateshwar Mutyam, Heather Y Hathorne, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
August 17, 2013
Comparison of cystic fibrosis transmembrane conductance regulator (CFTR) and ciliary beat frequency activation by the CFTR Modulators Genistein, VRT-532, and UCCF-152 in primary sinonasal epithelial cultures
Bryant T Conger, Shaoyan Zhang, Daniel Skinner, et al.
Plos One
|
August 27, 2013
IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbations
George M Solomon, Carla Frederick, Shaoyan Zhang, et al.
Page
of 27
Search research articles
Search
Showing results (61-70 of 269) with videos related to
Sort By:
Page
of 27
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 22, 2020
Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis
Gabriela R Oates, Elizabeth Baker, Steven M Rowe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 20, 2024
Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL)
Elizabeth Baker, William T Harris, Jennifer S Guimbellot, et al.
Genes
|
June 4, 2020
Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis
Zhongyu Liu, Justin D Anderson, Lily Deng, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 3, 2007
Bioelectric effects of quinine on polarized airway epithelial cells
Eleanor Bates, Stacey Miller, Mariah Alexander, et al.
ERJ Open Research
|
October 1, 2025
<i>Aspergillus fumigatus</i> is influenced by mucus accumulation, airway inflammation and cystic fibrosis transmembrane conductance regulator function
T Spencer Poore, Anh Nguyen, Levi Schaefers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2014
Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor
Sonya L Heltshe, Nicole Mayer-Hamblett, Jane L Burns, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
September 3, 2020
G551D mutation impairs PKA-dependent activation of CFTR channel that can be restored by novel GOF mutations
Wei Wang, Lianwu Fu, Zhiyong Liu, et al.
Pediatric Pulmonology
|
April 14, 2020
Ataluren/ivacaftor combination therapy: Two N-of-1 trials in cystic fibrosis patients with nonsense mutations
Jacelyn E Peabody Lever, Venkateshwar Mutyam, Heather Y Hathorne, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
August 17, 2013
Comparison of cystic fibrosis transmembrane conductance regulator (CFTR) and ciliary beat frequency activation by the CFTR Modulators Genistein, VRT-532, and UCCF-152 in primary sinonasal epithelial cultures
Bryant T Conger, Shaoyan Zhang, Daniel Skinner, et al.
Plos One
|
August 27, 2013
IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbations
George M Solomon, Carla Frederick, Shaoyan Zhang, et al.
Page
of 27